AXSOME THERAPEUTICS, INC. (AXSM) Operating cash flow 2016–2025
AXSOME THERAPEUTICS, INC. (AXSM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$93.4MFY2025 · since FY2016: -$21.3M → -$93.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$93.4M | +27.3% |
| FY2024 | -$128.4M | +11.5% |
| FY2023 | -$145.1M | -24.5% |
| FY2022 | -$116.5M | -7.7% |
| FY2021 | -$108.2M | -37.9% |
| FY2020 | -$78.5M | -69.2% |
| FY2019 | -$46.4M | -54.3% |
| FY2018 | -$30.1M | -13.5% |
| FY2017 | -$26.5M | -24.4% |
| FY2016 | -$21.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AXSM financial trends
AXSM RevenueAXSM Net incomeAXSM Net marginAXSM Gross profitAXSM Gross marginAXSM Operating incomeAXSM Operating marginAXSM Free cash flowAXSM Capital expendituresAXSM Return on equityAXSM Stock buybacksAXSM Dividends paidAXSM Total assetsAXSM Total liabilitiesAXSM Shareholders’ equityAXSM overview →